Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 7 Mar 23 EFFECT Notice of effectiveness
- 1 Mar 23 POS AM Prospectus update (post-effective amendment)
- 26 Aug 22 424B3 Prospectus supplement
- 19 Aug 22 424B3 Prospectus supplement
- 10 Aug 22 424B3 Prospectus supplement
- 15 Jun 22 424B3 Prospectus supplement
- 9 Jun 22 424B3 Prospectus supplement
- 2 Jun 22 EFFECT Notice of effectiveness
- 1 Jun 22 424B3 Prospectus supplement
-
24 May 22 S-1 IPO registration
CRXTQ similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the use in this Registration Statement on Form S-1 of Clarus Therapeutics Holdings, Inc. of our report dated March 31, 2022, relating to the consolidated financial statements of Clarus Therapeutics Holdings, Inc., appearing in the Prospectus, which is part of this Registration Statement.
We also consent to the reference to our firm under the heading “Experts” in such Prospectus.
/s/ RSM US LLP
Chicago, Illinois
May 24, 2022
1